tiprankstipranks
Trending News
More News >
Toray Industries Inc (TRYIY)
OTHER OTC:TRYIY
Advertisement

Toray Industries (TRYIY) AI Stock Analysis

Compare
20 Followers

Top Page

TRYIY

Toray Industries

(OTC:TRYIY)

Rating:69Neutral
Price Target:
$15.00
▲(8.85%Upside)
Toray Industries scores moderately overall, supported by a strong financial foundation and steady cash flows. Technical indicators are neutral, indicating stable market conditions, while the valuation reflects a high P/E ratio offset by a robust dividend yield. The absence of earnings call and corporate events data limits additional insights.

Toray Industries (TRYIY) vs. SPDR S&P 500 ETF (SPY)

Toray Industries Business Overview & Revenue Model

Company DescriptionToray Industries, Inc. (TRYIY) is a multinational corporation headquartered in Tokyo, Japan, primarily engaged in the development and manufacturing of advanced materials and technologies. The company operates across several sectors, including fibers and textiles, performance chemicals, carbon fiber composite materials, environment and engineering, life sciences, and other businesses. Toray Industries is known for its innovative solutions that cater to various industries such as automotive, aerospace, electronics, and healthcare.
How the Company Makes MoneyToray Industries generates revenue through the production and sale of high-performance materials and technology solutions across its diverse business segments. The fibers and textiles segment contributes significantly to the company's earnings by providing materials for clothing, industrial applications, and home textiles. The performance chemicals segment involves the manufacture of resins, films, and other chemical products used in electronics, packaging, and construction. Carbon fiber composite materials are another key revenue stream, particularly in the aerospace and automotive sectors, where they are used for lightweight and durable components. Additionally, Toray's environment and engineering segment focuses on water treatment technologies and engineering services, while the life sciences division offers medical products and pharmaceuticals. The company's strategic partnerships and continuous investment in research and development also play crucial roles in enhancing its product offerings and expanding market presence, thereby contributing to its financial performance.

Toray Industries Earnings Call Summary

Earnings Call Date:May 14, 2025
(Q2-2025)
|
% Change Since: 4.79%|
Next Earnings Date:Aug 06, 2025
Earnings Call Sentiment Positive
The earnings call presents a strong financial performance with record high income and significant profit increases, alongside strategic initiatives in pricing and capital efficiency. However, challenges remain in asset values and specific segments like Life Science, with potential economic risks noted.
Q2-2025 Updates
Positive Updates
Record High Core Operating Income
Core operating income for the first 6 months reached JPY 79.1 billion, marking a 62.6% increase compared to the previous year and a record high for the period.
Significant Profit Increase
Profit increased by 92.3% to JPY 55.5 billion compared to the same period last year.
Revenue Growth Across Segments
Consolidated revenue for the 6 months increased by 7.9% to JPY 1,294.1 billion, with notable growth in the Performance Chemicals (10.3% increase) and Carbon Fiber Composite Materials (8.3% increase) segments.
Strategic Pricing and Structural Reform
Strategic pricing exceeded plans, contributing to a 2.1-point increase in core operating income margin. Structural reforms and profitability improvement projects like D Pro have also contributed positively.
Share Buyback and Capital Efficiency
Resolution to repurchase shares of common stock and a policy to improve capital efficiency by reducing cross-shareholdings by half over 3 years.
Positive Free Cash Flow
Free cash flow was positive at JPY 65.4 billion.
Negative Updates
Decrease in Assets and Liabilities
Total assets decreased by JPY 100.7 billion and total liabilities decreased by JPY 92.6 billion from the end of the previous fiscal year, affected by currency appreciation.
Life Science Segment Challenges
Core operating income in the Life Science segment decreased by JPY 0.1 billion to negative JPY 0.6 billion, impacted by the penetration of generic drugs and NHI drug price revisions.
Potential Downward Economic Risks
Potential risks include changes in U.S. fiscal and trade policies, prolonged real estate recession in China, and impacts of financial policies in the U.S. and Europe.
Company Guidance
In the earnings call for Q2 2025, Toray Group reported a significant financial upturn, with consolidated revenue for the first half of the fiscal year increasing by 7.9% to JPY 1,294.1 billion. Core operating income soared by 62.6% to JPY 79.1 billion, marking a record high, while profit surged by 92.3% to JPY 55.5 billion. The company highlighted its strategic initiatives, including a share buyback plan funded by the reduction of cross-shareholdings, aimed at enhancing capital efficiency. Segment-wise, Performance Chemicals led growth with a 134.2% rise in core operating income, supported by demand recovery and improved utilization rates, while the Carbon Fiber Composite Materials segment also saw a 54.4% increase in core operating income. The company revised its full-year forecast upwards, anticipating revenue of JPY 2,590 billion and a core operating income of JPY 145 billion, reflecting a robust performance outlook amidst a gradually recovering global economy.

Toray Industries Financial Statement Overview

Summary
Toray Industries shows strong financial performance with solid profitability and robust cash flow generation. The income statement highlights effective cost management and revenue growth, while the balance sheet indicates a solid asset base with manageable leverage. Cash flow analysis reveals high-quality earnings and operational stability.
Income Statement
78
Positive
Toray Industries shows a strong income statement with solid profitability metrics. The gross profit margin has remained stable, indicating effective cost management. Net profit margin improvements over the years highlight increased efficiency. Revenue growth rate was healthy, especially in the last fiscal year, showing recovery and expansion. Both EBIT and EBITDA margins indicate robust operational performance, supporting the company's profitability.
Balance Sheet
72
Positive
The balance sheet of Toray Industries is strong, characterized by a high equity ratio indicating a solid asset base funded by equity. The debt-to-equity ratio is moderate, suggesting manageable leverage levels. Return on equity is healthy, reflecting efficient use of equity capital, though improvements can be made in optimizing capital structure further.
Cash Flow
81
Very Positive
Cash flow analysis reveals a strong position with consistent operating cash flows exceeding net income, indicating high-quality earnings. Free cash flow growth is positive, allowing for reinvestment opportunities. The company exhibits a healthy operating cash flow to net income ratio, demonstrating efficient cash management and operational stability.
BreakdownMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue2.56T2.46T2.49T1.88T2.21T
Gross Profit505.89B443.52B420.83B377.50B438.36B
EBITDA265.29B207.84B219.00B252.43B206.08B
Net Income77.91B21.90B72.82B45.79B45.79B
Balance Sheet
Total Assets3.29T3.47T3.19T2.85T2.65T
Cash, Cash Equivalents and Short-Term Investments254.52B248.86B254.69B242.49B173.70B
Total Debt842.66B949.68B950.09B973.93B913.56B
Total Liabilities1.47T1.62T1.56T1.53T1.47T
Stockholders Equity1.71T1.74T1.54T1.24T1.10T
Cash Flow
Free Cash Flow75.78B51.55B43.00B89.11B85.62B
Operating Cash Flow255.03B185.68B145.21B211.59B225.77B
Investing Cash Flow-63.20B-121.00B-102.72B-97.87B-142.36B
Financing Cash Flow-188.52B-70.37B-57.38B-69.40B-67.59B

Toray Industries Technical Analysis

Technical Analysis Sentiment
Positive
Last Price13.78
Price Trends
50DMA
13.55
Positive
100DMA
13.44
Positive
200DMA
12.98
Positive
Market Momentum
MACD
0.04
Negative
RSI
56.90
Neutral
STOCH
93.36
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TRYIY, the sentiment is Positive. The current price of 13.78 is above the 20-day moving average (MA) of 13.55, above the 50-day MA of 13.55, and above the 200-day MA of 12.98, indicating a bullish trend. The MACD of 0.04 indicates Negative momentum. The RSI at 56.90 is Neutral, neither overbought nor oversold. The STOCH value of 93.36 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TRYIY.

Toray Industries Peers Comparison

Overall Rating
UnderperformOutperform
Sector (57)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
$2.17B28.908.32%1.48%1.17%-30.24%
69
Neutral
$11.11B21.744.47%0.09%-1.29%224.05%
57
Neutral
HK$26.04B4.10-2.03%5.50%-0.23%-68.02%
55
Neutral
$86.85M-15.73%2.51%32.95%
52
Neutral
$142.34M-17.61%0.80%34.28%-495.11%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TRYIY
Toray Industries
13.78
3.61
35.50%
AIN
Albany International
72.23
-18.53
-20.42%
LAKE
Lakeland Industries
14.96
-8.45
-36.10%
UFI
Unifi
4.73
-1.45
-23.46%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 24, 2025